Caribou Biosciences (CRBU) Deferred Taxes (2020)
Caribou Biosciences (CRBU) posted quarterly Deferred Taxes of $57000.0 for Q4 2020, up 126.76% quarter-over-quarter from -$213000.0 in Q3 2020.
Caribou Biosciences (CRBU) Deferred Taxes (2020) Analysis & Trends
Caribou Biosciences (CRBU) has reported Deferred Taxes for 1 consecutive years, with $57000.0 the latest figure, recorded in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.66 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Caribou Biosciences | 163.09 Mn | 50.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 57,000.00 |
| Sep 30, 2020 | -213,000.00 |